Want to see TSE:CL full AI Analyst Report?
CL Stock Chart & Stats
C$1.02
-C$0.03(-3.13%)
At close: 4:00 PM EDT
C$1.02
-C$0.03(-3.13%)
Day’s Range― - ―
52-Week RangeC$0.81 - C$3.12
Previous CloseN/A
Volume26.25K
Average Volume (3M)78.43K
Market Cap
C$379.02M
Enterprise ValueC$1.17B
Total Cash (Recent Filing)C$32.87M
Total Debt (Recent Filing)C$592.02M
Price to Earnings (P/E)―
Beta2.15
Next Earnings
Nov 06, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding355,588,680
10 Day Avg. Volume62,394
30 Day Avg. Volume78,434
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)1.22
Price to Sales (P/S)0.62
P/FCF Ratio10.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$2.53Price Target Upside148.38% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)-0.03
Revenue Forecast (FY)C$672.18M
Bulls Say, Bears Say
Bulls Say
Operating ImprovementPositive EBIT and EBITDA, alongside a roughly 48% gross margin, show that core cultivation, manufacturing, and selling activities can generate operating contribution. If maintained, this improvement provides a base for eventual bottom-line recovery and more efficient scaling.
Positive Operating Cash FlowPositive operating cash flow indicates that the business is generating cash from its ongoing activities despite reported losses. While coverage remains limited, continued improvement in cash conversion could support operations and reduce reliance on external funding over the medium term.
Integrated Sales ModelCresco’s presence across cultivation, manufacturing, wholesale, and owned retail provides multiple routes to reach regulated-market customers. This integrated model can support product distribution, brand visibility, and channel flexibility as state markets and consumer demand develop.
Bears Say
Persistent Net LossesDespite operating improvement, TTM net margin remains about -16%, so the company is not converting gross profit and operating earnings into bottom-line profit. Persistent losses can restrict internally funded growth and weaken financial resilience over the next several quarters.
Elevated LeverageDebt-to-equity of roughly 1.65 and negative ROE indicate that leverage remains heavy relative to current earnings power. This reduces balance-sheet flexibility, increases the importance of sustained operating improvement, and can constrain investment or other capital-allocation choices.
Unstable Cash ConversionThe sharp decline in free cash flow versus the prior year shows that earnings improvement has not translated consistently into self-funding capacity. Uneven cash conversion can limit the company’s ability to finance expansion, reduce debt, or absorb operating setbacks without additional funding.
Cresco Labs News
CL FAQ
What was Cresco Labs’s price range in the past 12 months?
Cresco Labs lowest stock price was C$0.81 and its highest was C$3.12 in the past 12 months.
What is Cresco Labs’s market cap?
Cresco Labs’s market cap is C$379.02M.
When is Cresco Labs’s upcoming earnings report date?
Cresco Labs’s upcoming earnings report date is Nov 06, 2026 which is in 13 days.
How were Cresco Labs’s earnings last quarter?
Cresco Labs released its earnings results on Aug 06, 2026. The company reported C$0.056 earnings per share for the quarter, beating the consensus estimate of -C$0.022 by C$0.078.
Is Cresco Labs overvalued?
According to Wall Street analysts Cresco Labs’s price is currently Undervalued.
Does Cresco Labs pay dividends?
Cresco Labs does not currently pay dividends.
What is Cresco Labs’s EPS estimate?
Cresco Labs’s EPS estimate is -0.02.
How many shares outstanding does Cresco Labs have?
Cresco Labs has 355,588,680 shares outstanding.
What happened to Cresco Labs’s price movement after its last earnings report?
Cresco Labs reported an EPS of C$0.056 in its last earnings report, beating expectations of -C$0.022. Following the earnings report the stock price went up 13.333%.
Which hedge fund is a major shareholder of Cresco Labs?
Currently, no hedge funds are holding shares in TSE:CL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Cresco Labs Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$2.53 (148.38% Upside)
C$2.53 (148.38% Upside)
Blogger Sentiment
Bullish
TSE:CL Sentiment 67%
Sector Average 66%
Sector Average 66%
Insider Transactions
Sold Shares
Worth C$206.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 3.3%
Last 30 Days ▼ 3.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.41%
12-Months-Change
Fundamentals
Return on Equity
-28.27%
Trailing 12-Months
Asset Growth
-6.27%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Cresco Labs
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy’s brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.
CL Company Deck
CL Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a cautiously optimistic outlook: management delivered solid Q1 margins and EBITDA from a streamlined cost structure, achieved meaningful operational and licensing wins (PA store expansion, Ohio openings, Kentucky harvest, Texas license) and provided constructive Q2 growth guidance (~+10% revenue). Offsets include near-term revenue headwinds from the planned California exit and Michigan excise tax, ongoing pricing compression, seasonal cash flow timing, and unresolved regulatory details around rescheduling (including the scope and timing of 280E relief). On balance, operational momentum, accretive M&A activity, and licensing progress outweigh the short-term market and regulatory challenges.View all TSE:CL earnings summariesCL Stock 12 Month Forecast
Average Price Target
C$2.53
▲(148.38% Upside)